Anti-KTN1 monoclonal antibody

Pre-made anti-KTN1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to KTN1/KTN1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1065-Ab-1/ GM-Tg-hg-IP1065-Ab-2Anti-Human KTN1 monoclonal antibodyHuman
GM-Tg-rg-IP1065-Ab-1/ GM-Tg-rg-IP1065-Ab-2Anti-Rat KTN1 monoclonal antibodyRat
GM-Tg-mg-IP1065-Ab-1/ GM-Tg-mg-IP1065-Ab-2Anti-Mouse KTN1 monoclonal antibodyMouse
GM-Tg-cynog-IP1065-Ab-1/ GM-Tg-cynog-IP1065-Ab-2Anti-Cynomolgus/ Rhesus macaque KTN1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1065-Ab-1/ GM-Tg-felg-IP1065-Ab-2Anti-Feline KTN1 monoclonal antibodyFeline
GM-Tg-cang-IP1065-Ab-1/ GM-Tg-cang-IP1065-Ab-2Anti-Canine KTN1 monoclonal antibodyCanine
GM-Tg-bovg-IP1065-Ab-1/ GM-Tg-bovg-IP1065-Ab-2Anti-Bovine KTN1 monoclonal antibodyBovine
GM-Tg-equg-IP1065-Ab-1/ GM-Tg-equg-IP1065-Ab-2Anti-Equine KTN1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1065-Ab-1/ GM-Tg-hg-IP1065-Ab-2; GM-Tg-rg-IP1065-Ab-1/ GM-Tg-rg-IP1065-Ab-2;
GM-Tg-mg-IP1065-Ab-1/ GM-Tg-mg-IP1065-Ab-2; GM-Tg-cynog-IP1065-Ab-1/ GM-Tg-cynog-IP1065-Ab-2;
GM-Tg-felg-IP1065-Ab-1/ GM-Tg-felg-IP1065-Ab-2; GM-Tg-cang-IP1065-Ab-1/ GM-Tg-cang-IP1065-Ab-2;
GM-Tg-bovg-IP1065-Ab-1/ GM-Tg-bovg-IP1065-Ab-2; GM-Tg-equg-IP1065-Ab-1/ GM-Tg-equg-IP1065-Ab-2
Products NameAnti-KTN1 monoclonal antibody
Formatmab
Target NameKTN1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-KTN1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1065-Ag-1Recombinant multi-species KTN1/ CG1/ KNT protein


    Target information

    Target IDGM-IP1065
    Target NameKTN1
    Gene ID3895,16709,361029,697744,480332,101082241,537619,100050521
    Gene Symbol and SynonymsCG1,KNT,KTN1,MU-RMS-40.19
    Uniprot AccessionQ86UP2
    Uniprot Entry NameKTN1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000126777
    Target ClassificationTumor-associated antigen (TAA)

    The target: KTN1, gene name: KTN1, also named as CG1, KNT, MU-RMS-40.19. This gene encodes an integral membrane protein that is a member of the kinectin protein family. The encoded protein is primarily localized to the endoplasmic reticulum membrane. This protein binds kinesin and may be involved in intracellular organelle motility. This protein also binds translation elongation factor-delta and may be involved in the assembly of the elongation factor-1 complex. Alternate splicing results in multiple transcript variants of this gene. [provided by RefSeq, Aug 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.